Literature DB >> 27036234

Impact of thyroid autoimmunity on cumulative delivery rates in in vitro fertilization/intracytoplasmic sperm injection patients.

David Unuane1, Brigitte Velkeniers2, Sander Deridder3, Bert Bravenboer2, Herman Tournaye4, Michael De Brucker5.   

Abstract

OBJECTIVE: To predict the impact of thyroid autoimmunity (TAI) on the probability of delivery after a defined number of treatment cycles, using analysis of cumulative delivery rates in patients with and without TAI.
DESIGN: Retrospective cohort study performed at the Center for Reproductive Medicine and Department of Endocrinology, University Hospital of Brussels, approved by the institutional review board of the hospital.
SETTING: University hospital. PATIENT(S): All patients who started their first IVF/intracytoplasmic sperm injection cycle at our fertility center between January 1, 2010 and December 31, 2011 were included. MAIN OUTCOME MEASURE(S): Live birth delivery after 25 weeks' gestation was taken as the primary endpoint of our study Cumulative delivery rates were calculated for both groups until six treatment cycles. INTERVENTION(S): All patients (in both groups) received the usual IVF treatment protocols (i.e., antagonist or agonist protocol). RESULT(S): In total 2,406 women who consulted our center were included. We included 333 patients with TAI and 2019 patients without TAI. In the TAI group the crude cumulative delivery rate after six cycles was 47%, whereas the expected cumulative delivery rate was 65%. In our control the crude cumulative delivery rate after six cycles was 47%, whereas the expected cumulative delivery rate was 76%. CONCLUSION(S): Our study did not confirm an influence of TAI status in patients undergoing fertility treatment on cumulative delivery rates after six IVF/intracytoplasmic sperm injection cycles.
Copyright © 2016 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Anti-TPO antibodies; cumulative delivery rates; hypothyroidism; thyroid autoimmunity

Mesh:

Substances:

Year:  2016        PMID: 27036234     DOI: 10.1016/j.fertnstert.2016.03.011

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  10 in total

Review 1.  The role of thyroid function in female and male infertility: a narrative review.

Authors:  S La Vignera; G Defeudis; R Mazzilli; S Medenica; A M Di Tommaso; G Fabozzi; V Zamponi; D Cimadomo; L Rienzi; F M Ubaldi; M Watanabe; A Faggiano
Journal:  J Endocrinol Invest       Date:  2022-08-09       Impact factor: 5.467

Review 2.  Thyroid Autoimmunity in Female Infertility and Assisted Reproductive Technology Outcome.

Authors:  Ines Bucci; Cesidio Giuliani; Giulia Di Dalmazi; Gloria Formoso; Giorgio Napolitano
Journal:  Front Endocrinol (Lausanne)       Date:  2022-05-26       Impact factor: 6.055

Review 3.  Risk factors of subclinical hypothyroidism and the potential contribution to miscarriage: A review.

Authors:  Shuhei So; Fumiko Tawara
Journal:  Reprod Med Biol       Date:  2020-03-18

4.  High-Normal Preconception TSH Levels Have No Adverse Effects on Reproductive Outcomes in Infertile Women Undergoing the First Single Fresh D5 Blastocyst Transfer.

Authors:  Yuchao Zhang; Wenbin Wu; Yanli Liu; Yichun Guan; Xingling Wang; Liting Jia
Journal:  Int J Endocrinol       Date:  2020-08-18       Impact factor: 3.257

5.  Preconceptional antithyroid peroxidase antibodies, but not thyroid-stimulating hormone, are associated with decreased live birth rates in infertile women.

Authors:  Aimee Seungdamrong; Anne Z Steiner; Clarisa R Gracia; Richard S Legro; Michael P Diamond; Christos Coutifaris; William D Schlaff; Peter Casson; Gregory M Christman; Randal D Robinson; Hao Huang; Ruben Alvero; Karl R Hansen; Susan Jin; Esther Eisenberg; Heping Zhang; Nanette Santoro
Journal:  Fertil Steril       Date:  2017-10-25       Impact factor: 7.329

6.  Increased levels of CCR7(lo)PD-1(hi) CXCR5+ CD4+ T cells, and associated factors Bcl-6, CXCR5, IL-21 and IL-6 contribute to repeated implantation failure.

Authors:  Qiaoqiao Gong; Yuejie Zhu; Nannan Pang; Haiquan Ai; Xiaoyun Gong; Xiaolin La; Jianbing Ding
Journal:  Exp Ther Med       Date:  2017-10-18       Impact factor: 2.447

7.  A post-publication analysis of the idealized upper reference value of 2.5 mIU/L for TSH: Time to support the thyroid axis with magnesium and iron especially in the setting of reproduction medicine.

Authors:  Roy Moncayo; Helga Moncayo
Journal:  BBA Clin       Date:  2017-03-19

8.  'Does levothyroxine improve pregnancy outcomes in euthyroid women with thyroid autoimmunity undergoing assisted reproductive technology?'

Authors:  Kris Poppe; Flora Veltri; Candice Autin
Journal:  Thyroid Res       Date:  2018-05-30

9.  Protein Expression Profile in IVF Follicular Fluid and Pregnancy Outcome Analysis in Euthyroid Women with Thyroid Autoimmunity.

Authors:  Yuting Liu; Yijia Wu; Mingyuan Tian; Wenwen Luo; Chanyu Zhang; Yongjian Liu; Ke Li; Wei Cheng; Dongfang Liu
Journal:  ACS Omega       Date:  2020-05-14

10.  The Impact of Preconception TSH on the Reproductive Outcomes of Infertile Women Undergoing the First Fresh D3 Embryo Transfer Cycle.

Authors:  Yuchao Zhang; Wenbin Wu; Yanli Liu; Yichun Guan; Xingling Wang; Liting Jia
Journal:  Int J Endocrinol       Date:  2020-11-12       Impact factor: 3.257

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.